Приказ основних података о документу

dc.creatorMarinković, Dragan
dc.creatorZhang, Xin
dc.creatorYalcin, Safak
dc.creatorLuciano, Julia P.
dc.creatorBrugnara, Carlo
dc.creatorHuber, Tara
dc.creatorGhaffari, Saghi
dc.date.accessioned2021-06-09T13:17:42Z
dc.date.available2021-06-09T13:17:42Z
dc.date.issued2007
dc.identifier.issn0021-9738
dc.identifier.urihttp://rfasper.fasper.bg.ac.rs/handle/123456789/118
dc.description.abstractErythroid cells accumulate hemoglobin as they mature and as a result are highly prone to oxidative damage. However, mechanisms of transcriptional control of antioxidant defense in erythroid cells have thus far been poorly characterized. We observed that animals deficient in the forkhead box O3 (Foxo3) transcription factor died rapidly when exposed to erythroid oxidative stress-induced conditions, while wild-type mice showed no decreased viability. In view of this striking finding, we investigated the potential role of Foxo3 in the regulation of ROS in erythropoiesis. Foxo3 expression, nuclear localization, and transcriptional activity were all enhanced during normal erythroid cell maturation. Foxo3-deficient erythrocytes exhibited decreased expression of ROS scavenging enzymes and had a ROS-mediated shortened lifespan and evidence of oxidative damage. Furthermore, loss of Foxo3 induced mitotic arrest in erythroid precursor cells, leading to a significant decrease in the rate of in vivo erythroid maturation. We identified ROS-mediated upregulation of P21(CIP1/WAF1/Sdi1) (also known as Cdkn1a) as a major contributor to the interference with cell cycle progression in Foxo3-deficient erythroid precursor cells. These findings establish an essential nonredundant function for Foxo3 in the regulation of oxidative stress, cell cycle, maturation, and lifespan of erythroid cells. These results may have an impact on the understanding of human disorders in which ROS play a role.en
dc.publisherAmer Soc Clinical Investigation Inc, Ann Arbor
dc.relationUnited States Department of Health & Human Services, National Institutes of Health (NIH), National Heart Lung & Blood Institute (NHLBI) [HL076510-01, K18 HL076510]
dc.relationUnited States Department of Health & Human Services, National Institutes of Health (NIH), National Heart Lung & Blood Institute (NHLBI) [K18HL076510]
dc.rightsopenAccess
dc.sourceJournal of Clinical Investigation
dc.titleFoxo3 is required for the regulation of oxidative stress in erythropoiesisen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage2144
dc.citation.issue8
dc.citation.other117(8): 2133-2144
dc.citation.rankaM21
dc.citation.spage2133
dc.citation.volume117
dc.identifier.doi10.1172/JCI31807
dc.identifier.fulltexthttp://rfasper.fasper.bg.ac.rs/bitstream/id/139/115.pdf
dc.identifier.pmid17671650
dc.identifier.scopus2-s2.0-34547699517
dc.identifier.wos000248478100021
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу